Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)

Clinical trial NCT00983255 · COMPLETED

Trial details

NCT number: NCT00983255
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2009-09-01
Primary completion: 2010-01-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.